Relationships Relationships

Similar documents
Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

IN-PATIENT PEDIATRIC REHABILITATION

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Outcomes of Infants with Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Understanding the Impact of Drugs on Children. Jackie McReynolds Washington State University

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS

Effects of Prenatal Illicit Drug. Use on Infant and Child

Marijuana During Pregnancy: An Overview

Neonatal abstinence syndrome

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Common Drugs of Abuse. Tobacco/Nicotine Cannabis Alcohol Opiates Cocaine Methamphetamine. 36 weeks gestation adult

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Understanding Prenatal Drug Exposure

Neonatal Drug Withdrawal

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Brain Development and the Impact of Trauma

Neonatal Abstinence Syndrome Epidemiology, diagnosis, management and prevention

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)

Prenatal Substance Exposure: Maternal Screening and Neonatal Identification and Management Ira J. Chasnoff. DOI: /neo.

Born on Opioids 11/15/2018. Current Epidemic of Opiates. Opioid Exposed Infant. Khalid Awad, MD

The Impact of the Opioid Crisis on Children

Clinical Policy: Neonatal Abstinence Syndrome Guidelines Reference Number: CP.MP.86 Effective Date: 10/13

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Substance Use During Pregnancy. I have no conflicts of interest or relevant financial relationships with any commercial entities.

Objectives. Nothing to Disclose No Conflicts of Interest

Nursing Care of the NAS Infant. Lori Markham MSN, MBA, ARNP, NNP-BC

The Mystery of Risk. Drugs, Alcohol, Pregnancy and the Vulnerable Child. Ira J. Chasnoff, MD

Understanding Addiction: Why Can t Those Affected Just Say No?

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Neonatal Abstinence Syndrome

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Neonatal Abstinence: It s No Child s Play!

Wales Neonatal Network Guideline

Production by. Faculty Disclosure. Program Objectives. Accreditation. Methamphetamine Use: Maternal, Fetal and Neonatal Effects

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

Neonatal Abstinence Syndrome:

Neurodevelopmental Risk?

Summary of Changes: References/content updated to reflect most current standards of practice.

PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

American Academy of Pediatrics 2014 Educational Webinar Series Monday, July 28, 3:00 3:30 pm ET

Objectives. Common Drugs leading to NAS. Differential Diagnosis. Clinical Features of NAS. Assessing Neonatal Abstinence in the Newborn Nursery

Running head: NEONATAL ABSTINENCE SYNDROME 1

Safe Babies Foster Parent Training Program

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

A System of Care Surrounding the Drug Exposed Neonate. Disclosures. Objectives 11/17/2015. I have no financial disclosures

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Toxicology aspects of SUDI. Dr Stephen Morley STH

Marijuana Use During Pregnancy and Breastfeeding Findings Summary

Prenatal Substance Abuse: Improving Outcomes

EFFECTS OF PRENATAL EXPOSURES. Thomas J. Schreiner M.D. CAPT., USPHS White Earth Health Center

Goal: To identify the extent to which different aspects of brain structure and brain processes might offer explanations for different forms of

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Feeding Disorders and Growth in Williams Syndrome

NAS / NOWS: Description. Disclosures: I will discuss off-label uses of medications I have no financial disclosures. Objectives

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.

Susan M. Stephens, MD, FAAP Medical Director Comprehensive Medical and Dental Program Arizona Department of Child Safety

The Neurobiology of Addiction

The Substance Exposed Newborn Alphabet Soup

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Physical & Psychological Harms of Psychotropic Substance Abuse on Women. Seminar organized by HKCSS Dr. M Lam, SMO, CPH 18 Jan 2008

Goal: To identify the extent to which different aspects of brain structure and brain processes might offer explanations for different forms of

Across the Lifespan Questions Developmental Psychologists Ask

Research Paper 21/08/

Teresa s Background. Close Family. Sources. The Faces of FASD. Today We Will Learn About

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Substance-Exposed Newborn

Antidepressants in pregnancy Not USFDA approved in pregnancy, but commonly used medications:

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Supplementary Appendix

nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727

BRAIN MECHANISMS OF REWARD AND ADDICTION

Recreational Pharmaceuticals

25/04/2017. Many misconceptions, and much resistance to use Patients worry about it in pregnancy

Psychotropic Drugs Critical Thinking - KEY

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Department of Psychiatry\Behavioral Health 200 Mercy Drive, Suite 201 Dubuque, IA or

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

Neonatal Intensive Care Unit Clinical Guideline. Abstinence and Withdrawal in Neonates. Background

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

MENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN

T H E S C I E N C E O F E A R LY B R A I N D E V E L O P M E N T. Kristen V.W. Connolly, MD Pediatrician

Goodnight: The Importance of Sleep in Infants & Toddlers Ages 0-2 Years

EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy

4/19/2017. Neonatal Abstinence Syndrome. Disclosures. Objectives. Kara Kuhn-Riordon, MD UC Davis Medical Center. I have no financial disclosures

Depression in Pregnancy

Effects of Drugs on the Brain and Behavior in Adolescents

Understanding Alcohol And Other Drugs Of Abuse

The Nervous System. Nerves, nerves everywhere!

Autism: Practical Tips for Family Physicians

Transcription:

PRENATAL OPIATE EXPOSURE IMPACT ON EARLY CHILDHOOD LEARNING AND BEHAVIOR Ira J. Chasnoff, MD NTI Upstream www.ntiupstream.com Children grow and develop in the context of Attachment: Basic Concept Attachment: Where to start? Attachment is the interconnectedness between human beings. Attachment requires reading each other s cues responding appropriately to each other s cues. Mother Child Mother Child When does risk happen? Embryonic Period Conception Embryonic Fetal Early childhood Newborn Infant Toddler Preschool Childhood Primary grades Middle School Adolescence Embryonic First 12 weeks after conception Cells are undedicated (stem cells) Cells become imprinted during this phase Early gestational stress marks the genes Adds a methyl group to the gene (methylation) Becomes fixed as memory: epigenetic memory 1

Fetal Period Genes can be changed through fetal experiences Seratonin Shapes neuronal circuits in the frontal brain Provided to frontal brain via the placenta Cortisol Response to maternal fear, anxiety Transmitted to fetus via placenta Fetus is learning what to expect in the outer world Two Essential Caregiver Qualities Accessibility Responsiveness Six Factors Affecting in Chemically Dependent Women Negative heritage Emotional instability Lack of social support Cognitive functioning Psychological functioning Substance abuse Chronic administration of drugs of abuse, such as opiates or cocaine, substantially reduces oxytocin levels in the hypothalamus. Just in case you didn t get it Attachment: What about the baby? Mother Child 2

Biological Basis of the Effects of Prenatal Drug Use: The Catecholamine System Biological Basis of the Effects of Prenatal Drug Use: Methamphetamine Catecholamines Catecholamines Biological Basis of the Effects of Prenatal Drug Use: Cocaine Catecholamines Cocaine The Action of Opiates The nucleus accumbens Three types of neurons participate in opiate action: 1. opiates (green) bind to opiate receptors (yellow) 2. this decreases GABA release (inhibits dopamine release) 3. this sends a signal to the dopamine terminal to release more dopamine. *gamma Aminobutyric acid acid Prenatal opiate exposure Prenatal opiate exposure increased rates of: Low birth weight Low birth length Small birth head circumference Stillbirth SIDS 3

Some key questions What is true neonatal withdrawal? Is it the same as abstinence? How does NAS differ from neurobehavioral difficulties? What factors affect diagnostic labeling? Is it in fact important to differentiate NAS and neurobehavioral difficulties? Does the diagnosis affect treatment? Some definitions. Addiction a state in which an organism engages in a compulsive behavior the behavior is reinforcing loss of control in limiting intake Dependence a state in which an organism functions normally only in the presence of a drug manifested as a physical disturbance when the drug is removed Abstinence the practice of restraining oneself from indulging in something Withdrawal the unpleasant physical and mental effects that result when you stop doing or taking something Neurobehavioral of or relating to the relationship between the action of the nervous system and behavior Why is the question of withdrawal vs. neurobehavior so difficult to address? Small or highly selected samples Difficulty of prospectively collecting measures of substance use Lack of control for potential confounders with varying levels of adjustment Differences in study design and outcome measures Variance in terminology (addiction vs. dependence, abstinence vs. withdrawal, NAS vs. NDS) Polydrug use Physiology of adults does not necessarily translate to understanding physiology of the fetus or newborn Physiologic effect in fetus is more complex than in adults Immature neurologic development Immature neurologic processing Complex maternal/fetal/placental pharmacokinetics Prolonged half life in fetus Neonatal Abstinence Syndrome NAS the collection of signs and symptoms that occur when a newborn prenatally exposed to opiates experiences opioid withdrawal. Develops in 2 11 55 94% of opioid drug exposed infants Does not represent addiction in the newborn Does it represent dependence? Neonatal Abstinence Syndrome Onset: may be present at birth Peak: three to four days Acute phase: up to six weeks Subacute phase: up to 7 to 8 months NTI Upstream, 2018 4

Nonnarcotic Drugs That Cause Neonatal Psychomotor Behavior Consistent With Withdrawal Alcohol Hyperactivity, crying, irritability, poor suck, tremors, seizures, onset of signs at birth, poor sleeping pattern, hyperphagia, diaphoresis Barbiturates Irritability, severe tremors, hyperacusis, excessive crying, vasomotor instability, diarrhea, restlessness, increased tone, hyperphagia, vomiting, disturbed sleep SSRIs Irritability, constant crying, shivering, increased tonus, eating and sleeping difficulties and convulsions Diazepam Hypotonia, poor suck, hypothermia, apnea, hypertonia, hyperreflexia, tremors, vomiting, hyperactivity, tachypnea Neurobehavior of or relating to the relationship between the action of the nervous system and behavior interactions with and response to internal and external environment Substances associated with neurobehavioral changes Nicotine Alcohol Marijuana Cocaine Methamphetamine PCP Opiates Neurobehavior: Information Processing Model Four domains of information processing Input (recording information) Integration (interpreting input) Memory (storing input for later use) Output (appropriate use of language and motor skills) Neurobehavior Management Key domains Orientation the ability to attend to specific stimuli (auditory and visual) State regulation the ability to regulate state of arousal Supportive Swaddling Pacifier Low lighting Oscillating crib Avoidance of abrupt changes Frequent small feedings NAS only: Pharmacologic 5

So what is the difference between withdrawal and neurobehavioral deficits? Neurodevelopmental Disorder Neurocognitive functioning Adaptive functioning Self regulation Impact of Regulatory Difficulties State Regulation and Arousal Sleep States Habituation Reflex Development Self-soothing Attention Transitions Modulation of Affect ntiupstream.com 6